mild-to-moderate active ulcerative colitis research hub

A Randomized, Double-Blind, Placebo Controlled, Multi - Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis

This study is looking for volunteers aged 18 and over with mild to moderate ulcerative colitis. It aims to test a new medicine called LIV001 to see if it is safe and if people can tolerate it well. The study compares LIV001 with a dummy medicine (placebo).